1. Brown C (1990) Chirality in drug design and synthesis. Academic Press, London
2. Federsel HJ (2007) Chiral drug discovery and development from concept stage to market launch. In: Triggle DJ, Taylor JB (eds) Comprehensive medicinal chemistry II, vol 2. Elsevier, Amsterdam
3. Soudijn W (1983) Advantages and disadvantages in the application of biological racemates of specific isomers in drugs. In: Stereochemistry and biological activity of drugs. Blackwell Scientific Publications: Oxford
4. Borman S (1992) FDA issues flexible policy on chiral drugs. Chem Eng News 70:5
5. Yamaguchi T, Iwanami N, Shudo K, Saneyoshi M (1994) Chiral discrimination of enantiomeric 2′-deoxythymidine 5′-triphosphate by HIV-1 reverse transcriptase and eukaryotic DNA polymerases. Biochem Biophys Commun 200:1023–1027